The global medical robotics market is is projected to reach USD 16.74 billion by 2023 from an estimated USD 6.46 billion in 2018, at a CAGR of 21.0%, according to a report recently published by MarketsandMarkets™. The key driving factor for the growth of this market is increasing demand for more accurate surgeries to leave no room for human errors and ensure precision.
XACT™ technology is unique in its ability to accurately and repeatedly deliver needles/tools to desired targets through soft tissue with a proven accuracy of less than 1.5mm. XACT™ can apply to a wide range of applications, procedures and target organs using different imaging systems within the image guided and robot-assisted surgery market.
The first generation of the XACT™ System, currently available to patients in two active Clinical Centers of Excellence, is used to perform ablations, biopsies and other interventional procedures performed under image guidance by interventional radiologists.
The market is in need of a safe, accurate, and predictable method for performing interventional image-guided procedures, which will allow more interventional radiologists to safely and effectively treat more patients in need.